Clinical Trial Update: 24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating a single-fraction 24 Gy urethral-sparing HDR-like SBRT regimen for localized prostate cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Localized Prostate Carcinoma | NA | Status: RECRUITING